Patents Assigned to IMM Licensing LLC
  • Composition comprising combination of rapamycin and metformin and use thereof for treating neurodegenerative diseases
    Patent number: 12409170
    Abstract: A formulation for treating neurodegenerative diseases comprising a combination of rapamycin and metformin in a molar ratio of about 20:1, 10:1, 5:1, 4:1, 3:1, or 1:1. A method of treating neurodegenerative diseases comprising administering the formulation comprising a combination of rapamycin and metformin in a molar ratio of about 20:1, 10:1, 5:1, 4:1, 3:1, or 1:1.
    Type: Grant
    Filed: December 22, 2023
    Date of Patent: September 9, 2025
    Assignee: IMM Licensing LLC
    Inventor: Jeffrey M. Melin